mycoplasma
pneumonia
swine
mp
global
endem
chronic
respiratori
diseas
swine
industri
diseas
induc
mainli
mycoplasma
hyopneumonia
infect
caus
sizeabl
econom
loss
due
increas
veterinari
cost
product
loss
thacker
et
al
mae
et
al
hyopneumonia
locat
lumina
respiratori
tract
well
mucos
surfac
trachea
bronchi
bronchiol
blanchard
et
al
propag
tracheal
bronchial
surfac
infect
mp
bronchial
bronchiolar
epithelia
show
loss
cilia
epitheli
cell
slough
epitheli
cell
airway
lumina
redondo
et
al
primari
clinic
sign
sporad
dri
nonproduct
cough
thacker
et
al
destruct
cilia
hyopneumonia
increas
morbid
pathogen
pasteurella
multocida
porcin
respiratori
viru
reproduct
syndrom
viru
porcin
circoviru
type
porcin
respiratori
coronaviru
ciprian
et
al
thacker
et
al
kim
et
al
mae
et
al
sever
strategi
control
infecti
diseas
swine
commonli
employ
improv
hous
condit
use
antimicrobi
agent
vaccin
howev
measur
complet
erad
involv
pathogen
inhibit
transmiss
residu
antibiot
livestock
product
antibacteri
substanc
domest
anim
heavili
regul
japan
ministri
agricultur
forestri
fisheri
japan
therefor
safer
effici
way
control
swine
chronic
respiratori
diseas
necessari
point
view
genet
anim
breed
select
diseas
resist
use
ultim
minim
need
medic
exampl
kadowaki
et
al
improv
landrac
breed
popul
select
resist
mp
greater
meat
product
miyagi
prefectur
anim
industri
experi
station
previous
report
immun
respons
landrac
line
sheep
red
blood
cell
srbc
katayama
et
al
hyopneumonia
vaccin
sensit
shimazu
et
al
howev
relationship
mp
lung
lesion
immun
respons
report
therefor
present
studi
compar
mp
diseas
resist
landrac
pig
landrac
pig
assess
lung
lesion
immunogen
characterist
experiment
anim
maintain
convent
pig
barn
miyagi
univers
school
food
agricultur
environment
scienc
confirm
repeat
two
experi
conduct
experi
use
castrat
landrac
pig
averag
age
week
select
lower
level
mp
lesion
five
gener
miyagi
prefectur
anim
industri
experi
station
kadowaki
et
al
castrat
landrac
pig
research
develop
center
nippon
meat
packer
inc
hokkaido
japan
experi
use
six
describ
castrat
landrac
pig
averag
week
age
six
castrat
landrac
pig
fukushima
livestock
experi
station
experiment
anim
procedur
approv
tohoku
univers
miyagi
univers
regul
concern
protect
care
experiment
anim
experi
well
experi
anim
line
bred
group
allow
acclimat
month
experi
began
pig
rais
crude
barn
bed
rice
husk
bed
neither
chang
clean
excrement
remov
experi
order
provid
stress
condit
bad
environ
experiment
period
hypneumonia
vaccin
merial
japan
ltd
tokyo
japan
consist
inactiv
adjuv
prepar
inject
intramuscularli
twice
day
day
blood
collect
thu
day
defin
day
second
dose
vaccin
administ
immun
function
analys
sampl
conduct
day
blood
sampl
collect
via
jugular
venipunctur
vacuum
tube
contain
heparin
ethylenediaminetetraacet
acid
edta
terumo
tokyo
japan
sampl
time
salivari
sampl
collect
oral
caviti
cotton
swab
order
confirm
presenc
pathogen
hyopneumonia
sampl
nasal
mucu
anim
blood
sampl
time
day
pig
kill
stun
anatomi
facil
tohoku
univers
immun
tissu
collect
time
pulmonari
mp
lesion
confirm
measur
veterinarian
experi
half
pig
six
six
kill
day
remain
pig
remain
reach
bodi
weight
approxim
kg
averag
age
week
transport
slaughterhous
day
experiment
period
slaughter
miyagi
prefectur
meat
market
center
slaughter
pulmonari
mp
lesion
examin
blood
sampl
collect
anim
day
slaughter
pulmonari
mp
lesion
confirm
score
accord
goodwin
lung
score
goodwin
train
veterinarian
total
number
white
blood
cell
wbc
peripher
blood
measur
use
autohemolyt
counter
celltec
nihon
koden
tokyo
japan
percentag
number
type
immun
cell
measur
flow
cytometri
assay
swine
blood
mix
salin
pb
allow
erythrocyt
sediment
blood
leukocyt
enrich
supernat
genovesi
et
al
yang
parkhous
upper
phase
retain
cell
wash
brief
resuspens
hypoton
ammonium
chlorid
solut
remov
erythrocyt
cell
stain
fluoresc
antibodi
pb
contain
vv
fetal
bovin
serum
fb
wv
sodium
azid
subject
flow
cytometri
analysi
cell
label
follow
primari
antibodi
biotin
phycoerythrin
pe
fluorescein
isothiocyan
fitc
unconjug
mous
immunoglobulin
abd
serotec
oxford
uk
bind
unlabel
monoclon
antibodi
visual
use
phycoerythrin
pe
f
streptavidin
bio
legend
san
diego
ca
usa
respect
antibodi
obtain
beckman
coulter
fullerton
ca
usa
unless
otherwis
state
stain
cell
analyz
use
cell
sorter
bd
bioscienc
franklin
lake
nj
usa
equip
cellquest
softwar
data
analyz
use
flowjo
softwar
tree
star
ashland
usa
blood
sampl
collect
cervic
vein
anim
serum
separ
centrifug
g
min
divid
aliquot
store
analysi
plate
incub
hyopneumonia
vaccin
merial
japan
ltd
tokyo
japan
h
room
temperatur
nonspecif
bind
antigen
antibodi
plate
block
treatment
block
ace
ds
pharma
biomed
co
ltd
osaka
japan
h
room
temperatur
dilut
swine
serum
expos
plate
pool
swine
serum
use
standard
incub
h
wash
tri
buffer
salin
sigma
tokyo
japan
alkalin
igg
hl
antigen
rockland
immunochem
inc
philadelphia
pa
usa
ad
sampl
incub
h
detect
igg
wash
remov
nonspecif
bind
fluoresc
intens
measur
nm
interv
reaction
enzym
substrat
solut
salivari
sampl
collect
oral
caviti
anim
use
cotton
swab
saliva
separ
centrifug
g
min
divid
steril
microtub
watson
co
ltd
tokyo
japan
store
analysi
plate
incub
goat
iga
coat
antibodi
bethyl
laboratori
inc
montgomeri
tx
usa
h
room
temperatur
nonspecif
bind
antigen
antibodi
plate
block
treatment
postcoat
solut
bethyl
laboratori
inc
h
room
temperatur
dilut
swine
saliva
expos
plate
pig
refer
serum
use
standard
incub
h
room
temperatur
wash
tri
buffer
salin
horseradish
peroxidas
hrp
goat
iga
detect
antibodi
ad
sampl
incub
h
room
temperatur
detect
iga
min
incub
enzym
substrat
solut
reaction
stop
stop
solut
fluoresc
intens
measur
nm
peripher
blood
sampl
day
nonstimul
day
day
first
hyopneumonia
vaccin
use
assay
peripher
blood
mononuclear
cell
pbmc
isol
use
densiti
gradient
centrifug
individu
porcin
blood
sampl
wash
pb
roswel
park
memori
institut
medium
sigma
tokyo
japan
supplement
fb
mgml
streptomycin
uml
penicillin
next
cell
place
micropl
corn
costar
japan
tokyo
japan
cellswel
stimul
hyopneumonia
cellswel
hyopneumonia
j
atcc
strain
inactiv
formalin
lipopolysaccharid
lp
lp
escherichia
coli
prepar
use
phenol
extract
follow
chromatographi
sigma
concanavalin
cona
cell
maintain
atmospher
contain
incub
cell
radiolabel
kbqwell
ge
healthcar
tokyo
japan
incub
h
cell
harvest
glass
fiber
filter
perkinelm
japan
kanagawa
japan
incorpor
count
liquid
scintil
counter
beckman
instrument
palo
alto
ca
usa
subsequ
result
present
stimul
index
si
calcul
use
follow
equat
count
per
minuteintr
per
minuteinbackgroundcount
per
minuteincontrol
per
minuteinbackground
comparison
si
vaccin
sampl
rel
si
follow
equat
appli
relativesisifrom
vaccinationsifrom
vaccin
blood
sampl
collect
cervic
vein
anim
serum
separ
centrifug
g
min
divid
aliquot
store
analysi
concentr
interleukin
il
interferon
ifn
tumor
necrosi
factor
tnf
serum
sampl
determin
use
commerci
avail
elisa
kit
accord
manufactur
instruct
invitrogen
carlsbad
ca
usa
bethyl
laboratori
procedur
quantit
pcr
analysi
express
level
mrna
blood
previous
describ
shimazu
et
al
experi
express
level
mrna
total
blood
leukocyt
immun
tissu
peyer
patch
pp
mesenter
lymph
node
mln
hilar
lymph
node
hln
spleen
pulmonari
alveolar
macrophag
pam
analyz
quantit
pcr
peripher
blood
sampl
mix
trizol
ls
reagent
invitrogen
carlsbad
ca
usa
total
rna
extract
pam
collect
bronchoalveolar
lavag
fluid
centrifug
total
rna
pam
immun
tissu
extract
mix
ml
trizol
reagent
crush
bead
total
rna
concentr
extract
sampl
measur
use
nanodrop
spectrophotomet
thermo
fisher
scientif
wilmington
de
usa
total
rna
subject
revers
transcript
complementari
dna
cdna
synthes
use
primescript
rt
reagent
kit
genom
dna
gdna
eras
takara
tokyo
japan
accord
manufactur
recommend
quantit
pcr
perform
use
thermal
cycler
real
time
system
ii
takara
premix
ex
taq
ii
tli
rnaseh
plu
takara
condit
pcr
amplif
follow
follow
cycl
final
express
use
normal
variat
total
cdna
level
sampl
sampl
primer
sequenc
use
previous
describ
moue
et
al
plasma
concentr
growth
hormon
gh
measur
radioimmunoassay
porcin
gh
nation
hormon
peptid
program
medic
center
torranc
ca
usa
use
antigen
standard
porcin
gh
antiserum
nation
hormon
peptid
program
use
dilut
detect
limit
ngtube
coeffici
variat
gh
data
analyz
use
sa
mix
procedur
sa
cari
nc
usa
fix
effect
pig
line
select
landrac
landrac
day
experi
random
effect
anim
compar
mean
chang
two
line
vaccin
less
consid
statist
signific
first
confirm
hyopneumonia
dna
nasal
swab
pig
use
two
experi
data
shown
confirm
bacterium
indigen
pig
experi
experi
found
mp
lung
lesion
score
significantli
lower
landrac
line
landrac
line
fig
two
landrac
line
introduc
differ
farm
differ
genet
background
breed
environ
line
also
show
significantli
lower
lung
lesion
score
either
two
line
experi
signific
differ
number
wbc
peripher
blood
landrac
landrac
line
data
shown
howev
percentag
b
cell
decreas
previou
result
experi
shimazu
et
al
hyopneuonia
vaccin
significantli
higher
landrac
line
landrac
line
day
vaccin
fig
observ
signific
differ
number
immun
cell
landrac
landrac
line
although
signific
differ
hyopneumonia
igg
product
peripher
blood
line
line
experi
shimazu
et
al
experi
igg
tend
suppress
line
line
data
shown
addit
experi
iga
concentr
salivari
gland
day
second
vaccin
increas
line
increas
significantli
greater
line
line
fig
cell
prolifer
activ
landrac
line
vaccin
compar
preset
studi
stimul
pbmc
harvest
two
line
hyopneumonia
lp
cona
examin
prolif
abil
present
studi
experi
line
show
significantli
higher
si
valu
stimul
hyopneumonia
mp
vaccin
lp
mp
vaccin
fig
b
howev
statist
differ
rel
mitogen
activ
calcul
divid
si
valu
vaccin
si
valu
vaccin
observ
fig
studi
mrna
express
significantli
increas
line
day
vaccin
compar
line
fig
signific
differ
mrna
express
cytokin
landrac
landrac
line
observ
data
shown
concentr
measur
possibl
show
measur
elisa
kit
indic
valu
detect
limit
experi
mrna
express
pp
mln
spleen
pam
significantli
higher
landrac
line
line
howev
signific
differ
mrna
express
level
hln
pam
line
hand
mrna
express
pp
mln
spleen
pp
mln
significantli
higher
line
line
signific
differ
express
spleen
hln
pam
hln
pam
line
line
fig
experi
decreas
concentr
gh
significantli
greater
landrac
line
landrac
line
first
vaccin
day
shimazu
et
al
similarli
experi
gh
concentr
significantli
decreas
landrac
line
howev
increas
landrac
line
day
second
vaccin
fig
previou
report
clarifi
immun
respons
landrac
line
line
srbc
katayama
et
al
hyopneumonia
vaccin
shimazu
et
al
present
studi
confirm
repeat
observ
effect
immun
respons
compar
mp
resist
immun
respons
hyopneumonia
vaccin
landrac
line
landrac
line
landrac
line
use
two
experi
genet
differ
line
first
observ
signific
differ
mp
lung
lesion
score
landrac
line
two
landrac
line
expect
lung
lesion
score
significantli
lower
landrac
line
two
landrac
line
result
confirm
resist
mp
select
line
experi
variou
immun
trait
measur
therefor
calcul
correl
mp
lung
lesion
immun
trait
clarifi
immun
trait
relat
mp
lung
lesion
howev
could
get
signific
correl
nevertheless
mani
signific
differ
immun
trait
line
line
observ
experi
result
experi
shimazu
et
al
previou
result
katayama
et
al
possibl
humor
immun
character
b
cell
activ
suppress
line
vaccin
suggest
compar
landrac
line
percentag
b
cell
peripher
blood
experi
igg
secret
experi
prolif
abil
pbmc
experi
significantli
decreas
landrac
line
furthermor
result
confirm
previou
studi
igg
product
decreas
line
katayama
et
al
addit
previou
studi
indic
increas
igg
product
serum
directli
involv
clinic
resist
mycoplasma
pneumonia
thacker
et
al
chen
et
al
result
also
indic
increas
igg
product
like
contribut
mp
lung
lesion
sever
natur
infect
associ
suppress
igg
landrac
line
secret
gh
peripher
blood
significantli
suppress
experi
experi
shimazu
et
al
b
cell
major
immun
cell
express
gh
gh
receptor
hattori
et
al
hattori
gh
promot
lymphocyt
surviv
prolifer
jeay
et
al
borghetti
et
al
therefor
decreas
b
cell
percentag
gh
secret
prolif
abil
pbmc
line
suggest
trait
correl
donahu
et
al
report
secret
gh
increas
male
rat
femal
rat
diestru
expos
stressor
landrac
line
may
less
suscept
stress
landrac
line
howev
whether
increas
decreas
gh
involv
mp
resist
unclear
contrari
decreas
b
cell
igg
secret
salivari
iga
secret
increas
landrac
line
peripher
blood
igg
saliva
iga
produc
differ
tissu
organ
igg
monomer
type
iga
known
produc
lymph
node
spleen
bone
marrow
secret
blood
dimer
type
iga
secret
saliva
mainli
produc
tissu
secret
tear
saliva
sweat
colostrum
parham
mucos
immun
system
first
defens
line
inner
bodi
surfac
iga
essenti
surfac
defens
system
secret
iga
critic
protect
infecti
pathogen
phalipon
et
al
brandtzaeg
et
al
increas
iga
secret
may
also
play
protect
role
hyopneumonia
infect
upper
respiratori
tract
woolard
et
al
activ
mucos
immun
may
one
reason
lung
lesion
reduc
line
hand
natur
immun
immun
character
granular
leukocyt
percentag
protein
mrna
express
show
significantli
higher
landrac
line
two
landrac
line
increas
express
elimin
bacteria
parasit
activ
macrophag
killer
cell
romagnani
thacker
et
al
jone
et
al
woolard
et
al
also
play
import
role
pulmonari
defens
mechan
mycoplasma
respiratori
diseas
woolard
et
al
rodriguez
et
al
furthermor
immun
import
control
mp
thacker
et
al
chen
et
al
may
one
reason
increas
resist
mp
line
present
studi
experi
mrna
express
pp
mln
spleen
pam
significantli
higher
immun
tissu
obtain
line
line
differ
immun
respons
suggest
genet
correl
respons
accord
mp
select
recogn
molecular
pattern
tlr
famili
play
critic
role
host
defens
develop
inflamm
recogn
ligand
bacteria
wherea
respond
endotoxin
bacteria
tlr
also
involv
respons
lung
injuri
jiang
et
al
hyopneumonia
infect
chu
et
al
wu
et
al
love
et
al
primari
cytokin
respons
acut
inflamm
thacker
hyopneumonia
clearanc
lung
pietsch
et
al
wu
et
al
endogen
regul
critic
chemokin
express
acut
lung
inflamm
shanley
et
al
result
indic
interact
cytokin
tlr
may
contribut
balanc
inflammatori
immun
respons
lung
line
conclus
landrac
line
show
strong
resist
mp
due
strength
mucos
immun
respons
describ
furthermor
research
indic
immun
system
compon
salivari
iga
may
work
synergist
mp
present
studi
cytokin
tlr
level
mucos
tissu
pam
salivari
iga
measur
experi
therefor
necessari
confirm
repeat
result
addit
although
landrac
line
show
strong
resist
mp
studi
confirm
whether
line
resist
respiratori
chronic
diseas
warrant
